Targeting IL-13 as a Host-Directed Therapy Against Ulcerative Colitis

Abstract excerpt

The role of interleukin-13 in mediating ulcerative colitis remains under scrutiny. Compelling evidence from both man and mouse suggests that IL-13 not only contributes to the pathology associated with disease but is also involved in mediating the inflammatory response. These studies have led to the approach of targeting IL-13 as a promising treatment strategy in alleviating ulcerative colitis disease. Despite...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to IL-33, ST2, and ILC Pathways
• Share to Inflammatory Bowel Disease
• Share to Microscopic Colitis